Thomas Brodmerkel - 29 Nov 2022 Form 4 Insider Report for Mitesco, Inc. (MITI)

Reporting relationship: Chief Financial Officer, Director
Issuer ticker: MITI
Reported as of: 29 Nov 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Dec 2022, 10:09:44 UTC
Prior SEC filing: 22 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Thomas Brodmerkel

Key filing fact

Thomas Brodmerkel filed Form 4 for Mitesco, Inc. (MITI) on 06 Dec 2022.

Key facts

This page summarizes Thomas Brodmerkel's Form 4 filing for Mitesco, Inc. (MITI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Dec 2022, 10:09.

Change

Previous filing in this sequence was filed on 22 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MITI transaction Derivative

Common Stock Purchase Warrant

Purchase

Transaction value: $0
Shares: +37,500
Change %
Price: $0.000000
Shares after: 37,500
Date: 29 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,500
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On November 29, 2022, Mitesco, Inc. (the "Company") issued a 10% promissory note (the "Note") to Thomas Brodmerkel. The principal amount of the Note is $18,750 and carries a 10% interest rate per annum. 37,500 Common Stock Purchase Warrants were granted to Mr. Brodmerkel on November 29, 2022, pursuant to the Note at an exercise price priced at the same price as included in an offering in conjunction with listing at the Nasdaq Global Market. The Warrants are exercisable at any time on or after May 29, 2023, and on or before the November 29, 2027.